Eric Lefkofsky, founder and CEO of Tempest AI, explains the impact of acquiring Ambry, a genetic testing company, which ...

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares ...

At the Chicago-based company's first J.P. Morgan conference since going public in June, Tempus founder and CEO Eric Lefkofsky painted a bright and bold picture of the future of artificial ...

With Ambry Genetics in tow, Eric Lefkofsky's biotech startup hopes to accelerate its drive toward turning a profit. Northwestern Medicine will be the first system to use Tempus' new algorithm to ...

Just 10 days after Pelosi’s AI stock acquisition, the chief executive officer (CEO) of the company dumped $62 million worth ...

Tempus AI stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge and former House Speaker Nancy Pelosi revealed she's bet on the stock.

Shares of Tempus AI (TEM) are down 92c, or 2%, to $49.53 in Thursday morning trading after it was disclosed in a regulatory filing last night ...

CEO Eric Lefkofsky called it essential in patient care, making health data more accessible and actionable than ever. With AI's role in healthcare expanding fast, investors are paying close attention.

Now, as AI becomes increasingly integrated into healthcare, tools like Olivia will be essential in helping patients understand and navigate their care,” said Eric Lefkofsky, Founder and CEO of ...

neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Eric Lefkofsky, CEO and Chairman of Tempus AI , Inc. (NASDAQ:TEM), recently sold a significant portion of his holdings, ...

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares beginning on January 22, totaling about $62M. On January 22, Lefkofsky sold ...